Budeflo Inhaler 200/6 incorporates a combination of formoterol, budesonide, anti-inflammatory, corticosteroid and a long-acting bronchodilator, which is utilized to medicate chronic obstructive pulmonary disease (COPD) asthma, to control the symptoms as well as to improve the function of lungs.
Budeflo Rotacaps (Budesonide and Formoterol Fumarate Dihydrate capsules) -
Budeflo Rotacaps, an amalgamation of Budesonide and Formoterol Fumarate Dihydrate are to be managed to patients with asthma where usage of a combination (long acting Beta-2 adrenoceptor agonist and inhaled corticosteroid) is more suitable. It is also effectual for symptomatic treatment of patients with intense chronic obstructive pulmonary disease (COPD) and history of recurrent exacerbation, with significant indications despite regular medical aid with long-acting bronchodilators.
Budesonide is a steroid, which reduces the inflammation in the body. Formoterol is a bronchodilator that loosens up muscles in the airways to improve the breathing process.
For people with asthma: Budesonide and formoterol can be only taken if the person is suffering severe asthma or is not well-controlled on other long-run asthma medicines. Your doctor may advise you to stop the dosage of this medicine once your asthma attack is well-controlled.
The medicines can also be used for some purposes, which are not listed in the medication guide.
This medicament is only for use if the asthma attack is severe or is not well-controlled on other long-term asthma medicine, such as a breathe-in steroid.
Some common side effects of these medicines are: